chr19-12430191-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_005815.5(ZNF443):c.1981C>T(p.Leu661Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000471 in 1,613,306 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_005815.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF443 | NM_005815.5 | c.1981C>T | p.Leu661Phe | missense_variant | 4/4 | ENST00000301547.10 | NP_005806.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF443 | ENST00000301547.10 | c.1981C>T | p.Leu661Phe | missense_variant | 4/4 | 1 | NM_005815.5 | ENSP00000301547.5 | ||
ENSG00000268870 | ENST00000595562.1 | c.3+10721C>T | intron_variant | 4 | ENSP00000471613.1 |
Frequencies
GnomAD3 genomes AF: 0.0000789 AC: 12AN: 152048Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000319 AC: 8AN: 251014Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135790
GnomAD4 exome AF: 0.0000438 AC: 64AN: 1461144Hom.: 0 Cov.: 33 AF XY: 0.0000537 AC XY: 39AN XY: 726852
GnomAD4 genome AF: 0.0000789 AC: 12AN: 152162Hom.: 0 Cov.: 32 AF XY: 0.0000672 AC XY: 5AN XY: 74406
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 15, 2024 | The c.1981C>T (p.L661F) alteration is located in exon 4 (coding exon 4) of the ZNF443 gene. This alteration results from a C to T substitution at nucleotide position 1981, causing the leucine (L) at amino acid position 661 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at